Clinipad recalls contaminated woundcare products:
This article was originally published in Clinica
Clinipad, a US woundcare manufacturer, is voluntarily recalling its antiseptic sterile skin preparations on the grounds that the sterility of the products cannot be guaranteed. Rocky Hill, Connecticut-based Clinipad is mounting a nationwide recall of certain products produced since 1997 and widely distributed in the US to blood banks, hospitals and clinics. The company confirmed that some lots since December 1999 have been contaminated with Pseudomonas aeruginosa and Stenotrophomonas maltophila, although there are no known cases of blood contamination traceable to the Clinipad supplies.
You may also be interested in...
Health technology assessment body NICE says that Revlimid fights cancer cells in a different way to current treatments which should help reduce resistance and improve disease outcomes.
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.